Outsourced Pharma App Notes & Case Studies
-
Leveraging Softgel To Extend Vinorelbine's Lifecycle, Improve Patient Convenience
3/20/2026
Develop innovative oral formulations of traditionally intravenous therapies to enhance patient convenience, ensure consistent systemic exposure, and support long-term brand value and market differentiation.
-
Formulation Strategies For Enhancing Bioavailability Of Challenging bRo5 Molecules
3/20/2026
Leverage mechanistic, material-sparing formulation strategies to enhance bioavailability and accelerate development of challenging bRo5 small molecules, even with limited resources.
-
Lean Six Sigma Methodology Drives Cost Savings: 2 Success Stories
9/21/2025
Unlock significant lab efficiency and financial gains. See how focused optimization of workflows and asset management led to substantial cost savings and reclaimed six-figure value in consumables.
-
AOC GMP Manufacture For A FIH Study
12/5/2025
Successful development of AOCs for FIH studies requires robust GMP processes and efficient scale-up. A key step is careful management of a multi-day conjugation process with vital in-process checks.
-
Application Of A Dual Spiking Strategy In Viral Clearance Studies
2/3/2026
Explore how an alternative spiking strategy can streamline viral clearance studies, reduce material demands, and maintain compliance while addressing the challenges posed by MLV and MMV.
-
Accelerating Cold Chain Expansion: Responding To COVID-19 Challenges
8/21/2024
Review how leveraging cross-functional teamwork helped complete a cold chain infrastructure expansion in a fraction of the expected timeline, ensuring the production of essential COVID-19 therapeutics.
-
AOC Conjugation – mAb With SiRNA
12/5/2025
See how to overcome risks in mAb-SiRNA conjugation, including disulfide scrambling and SiRNA deconjugation, by using advanced chemical and operational solutions to improve material yield and stability.
-
Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines
3/24/2025
Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.
-
Overcoming The Solubility Challenges Of Antibody-Drug Conjugates
6/3/2024
Discover a chito-oligosaccharide that significantly improves the solubility of antibody-drug conjugates (ADCs) when included in the linker-payload construct.
-
Driving Seamless Tech Transfer Of Multiple Projects Within A Short Timeline
9/4/2025
Uncover how we were able to provide seamless technology transfers and uninterrupted production to deliver critical therapies efficiently and reliably to patients.